This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2000 Sep 15;18(18):3199-201.

doi: 10.1200/JCO.2000.18.18.3199.

Positron emission tomography: another useful test for staging esophageal cancer

PMID: 10986051
DOI: 10.1200/JCO.2000.18.18.3199

Editorial

Positron emission tomography: another useful test for staging esophageal cancer

C J Lightdale. J Clin Oncol. 2000.

. 2000 Sep 15;18(18):3199-201.

doi: 10.1200/JCO.2000.18.18.3199.

Author

PMID: 10986051
DOI: 10.1200/JCO.2000.18.18.3199

No abstract available

PubMed Disclaimer

Comment on

Utility of positron emission tomography for the staging of patients with potentially operable esophageal carcinoma.
Flamen P, Lerut A, Van Cutsem E, De Wever W, Peeters M, Stroobants S, Dupont P, Bormans G, Hiele M, De Leyn P, Van Raemdonck D, Coosemans W, Ectors N, Haustermans K, Mortelmans L. Flamen P, et al. J Clin Oncol. 2000 Sep 15;18(18):3202-10. doi: 10.1200/JCO.2000.18.18.3202. J Clin Oncol. 2000. PMID: 10986052 Clinical Trial.

Similar articles

Positron emission tomography in the staging of esophageal cancer.
Leccisotti L. Leccisotti L. Rays. 2006 Jan-Mar;31(1):9-12. Rays. 2006. PMID: 16999368 Review.
PET and PET-CT in esophageal and gastric cancer.
Wieder HA, Krause BJ, Herrmann K. Wieder HA, et al. Methods Mol Biol. 2011;727:59-76. doi: 10.1007/978-1-61779-062-1_5. Methods Mol Biol. 2011. PMID: 21331929
The role of 18F-FDG PET/CT in the evaluation of oesophageal carcinoma.
Chowdhury FU, Bradley KM, Gleeson FV. Chowdhury FU, et al. Clin Radiol. 2008 Dec;63(12):1297-309. doi: 10.1016/j.crad.2008.05.010. Epub 2008 Aug 21. Clin Radiol. 2008. PMID: 18996259 Review.
Esophageal cancer and head and neck cancer.
Lowe VJ, Stack BC Jr. Lowe VJ, et al. Semin Roentgenol. 2002 Apr;37(2):140-50. doi: 10.1016/s0037-198x(02)80033-5. Semin Roentgenol. 2002. PMID: 12134367 Review. No abstract available.
Staging an esophageal carcinoma by F-18 fluorodeoxyglucose whole-body positron emission tomography.
Hoegerle S, Altehoefer C, Nitzsche EU. Hoegerle S, et al. Clin Nucl Med. 2000 Mar;25(3):219-20. doi: 10.1097/00003072-200003000-00019. Clin Nucl Med. 2000. PMID: 10698427 No abstract available.

See all similar articles

Cited by

Potential impact of (18)FDG-PET/CT on surgical approach for operable squamous cell cancer of middle-to-lower esophagus.
Liu S, Zhu H, Li W, Zhang B, Ma L, Guo Z, Huang Y, Song P, Yu J, Guo H. Liu S, et al. Onco Targets Ther. 2016 Feb 22;9:855-62. doi: 10.2147/OTT.S97896. eCollection 2016. Onco Targets Ther. 2016. PMID: 26955283 Free PMC article.
Positron emission tomography with F-18-fluorodeoxyglucose in a combined staging strategy of esophageal cancer prevents unnecessary surgical explorations.
van Westreenen HL, Heeren PA, van Dullemen HM, van der Jagt EJ, Jager PL, Groen H, Plukker JT. van Westreenen HL, et al. J Gastrointest Surg. 2005 Jan;9(1):54-61. doi: 10.1016/j.gassur.2004.09.055. J Gastrointest Surg. 2005. PMID: 15623445
FDG-PET scanning in the management of cancer of the oesophagus and oesophagogastric junction: early experience with 100 consecutive cases.
Malik V, Keogan M, Gilham C, Duffy G, Ravi N, Reynolds JV. Malik V, et al. Ir J Med Sci. 2006 Oct-Dec;175(4):48-54. doi: 10.1007/BF03167967. Ir J Med Sci. 2006. PMID: 17312829

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information